Poulton Stuart - Insider Non-Derivative Transactions at Karyopharm Therapeutics Inc. (KPTI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jul 30, 2024, Poulton Stuart's relationship to Karyopharm Therapeutics Inc. (KPTI) is Officer (EVP, Chief Development Officer), and currently has 326,628 shares of Common Stock, and 329,511 shares of Common.
The the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other KPTI insiders.
Data Source: SEC.
Poulton Stuart - Insider Non-Derivative Transactions of KPTI Common Stock
Poulton Stuart - Insider Non-Derivative Transactions of KPTI Common
Poulton Stuart - Insider Non-Derivative Transactions at KPTI
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Jul 31, 2024 | Sell -- (Common Stock) | 2883 | 1.06 | 326628 |
Mar 2, 2024 | Sell -- (Common) | 6155 | 1.2 | 329511 |
Mar 1, 2024 | Sell -- (Common) | 16311 | 1.17 | 335666 |
Feb 29, 2024 | Acquisition -- (Common Stock) | 188205 | 0 | 351977 |
Feb 16, 2024 | Sell -- (Common Stock) | 99 | 1.4 | 163772 |
Feb 16, 2024 | Sell -- (Common Stock) | 5748 | 1.33 | 163871 |
Jan 25, 2024 | Acquisition -- (Common Stock) | 13333 | 0 | 169619 |
Jul 29, 2023 | Sell -- (Common Stock) | 2845 | 1.7 | 156286 |
Mar 1, 2023 | Acquisition -- (Common Stock) | 95000 | 0 | 159131 |
Feb 16, 2023 | Sell -- (Common Stock) | 196 | 3.16 | 64131 |
Feb 16, 2023 | Sell -- (Common Stock) | 8 | 3.23 | 64327 |
Feb 16, 2023 | Sell -- (Common Stock) | 5665 | 3.19 | 64335 |